CLSI EP32 R : 1ED 2006
|
METROLOGICAL TRACEABILITY AND ITS IMPLEMENTATION |
CLSI EP18 P2 : 2ED 2007
|
RISK MANAGEMENT TECHNIQUES TO IDENTIFY AND CONTROL LABORATORY ERROR SOURCES |
CLSI EP18 A2 : 2ED 2009
|
RISK MANAGEMENT TECHNIQUES TO IDENTIFY AND CONTROL LABORATORY ERROR SOURCES |
CLSI MM9 A2 : 2ED 2014
|
NUCLEIC ACID SEQUENCING METHODS IN DIAGNOSTIC LABORATORY MEDICINE |
CLSI EP26 A : 1ED 2013
|
USER EVALUATION OF BETWEEN-REAGENT LOT VARIATION |
CLSI EP25 A : 1ED 2009
|
EVALUATION OF STABILITY OF IN VITRO DIAGNOSTIC REAGENTS |
CLSI C58 A : 1ED 2011
|
ASSESSMENT OF FETAL LUNG MATURITY BY THE LAMELLAR BODY COUNT |
BIS IS/ISO 15189 : 2012
|
MEDICAL LABORATORIES - REQUIREMENTS FOR QUALITY AND COMPETENCE |
CLSI EP29 A : 1ED 2012
|
EXPRESSION OF MEASUREMENT UNCERTAINTY IN LABORATORY MEDICINE |
CLSI H60 A : 1ED 2014
|
LABORATORY TESTING FOR THE LUPUS ANTICOAGULANT |
I.S. EN ISO 15189:2012
|
MEDICAL LABORATORIES - REQUIREMENTS FOR QUALITY AND COMPETENCE (ISO 15189:2012, CORRECTED VERSION 2014-08-15) |
CLSI MM1 A3 : 3ED 2012
|
MOLECULAR METHODS FOR CLINICAL GENETICS AND ONCOLOGY TESTING |
CLSI POCT9 A : 1ED 2010
|
SELECTION CRITERIA FOR POINT-OF-CARE TESTING DEVICES |
CLSI MM22 A : 1ED 2014
|
MICROARRAYS FOR DIAGNOSIS AND MONITORING OF INFECTIOUS DISEASES |
CLSI I/LA28 A2 : 2ED 2011
|
QUALITY ASSURANCE FOR DESIGN CONTROL AND IMPLEMENTATION OF IMMUNOHISTOCHEMISTRY ASSAYS |
CLSI EP18 P3 : 3ED 2009
|
RISK MANAGEMENT TECHNIQUES TO IDENTIFY AND CONTROL LABORATORY ERROR SOURCES |
CLSI MM17 P : 1ED 2007
|
VERIFICATION AND VALIDATION OF MULTIPLEX NUCLEIC ACID ASSAYS |
CLSI H26 P2 : 2ED 2009
|
VALIDATION, VERIFICATION, AND QUALITY ASSURANCE OF AUTOMATED HEMATOLOGY ANALYZERS |
CLSI EP27 P : 1ED 2009
|
HOW TO CONSTRUCT AND INTERPRET AN ERROR GRID FOR DIAGNOSTIC ASSAYS |
CLSI H57 A : 1ED 2008
|
PROTOCOL FOR THE EVALUATION, VALIDATION, AND IMPLEMENTATION OF COAGULOMETERS |
CLSI C52 A2 : 2ED 2007
|
TOXICOLOGY AND DRUG TESTING IN THE CLINICAL LABORATORY |
CLSI EP17 A2 : 2ED 2012
|
EVALUATION OF DETECTION CAPABILITY FOR CLINICAL LABORATORY MEASUREMENT PROCEDURES |
CLSI EP14 A3 : 2014
|
EVALUATION OF COMMUTABILITY OF PROCESSED SAMPLES |
UNE-EN ISO 15189:2013
|
Medical laboratories - Requirements for quality and competence (ISO 15189:2012, Corrected version 2014-08-15) |
CLSI MM5 A2 : 2ED 2012
|
NUCLEIC ACID AMPLIFICATION ASSAYS FOR MOLECULAR HEMATOPATHOLOGY |
CLSI POCT9 P : 1ED 2009
|
SELECTION CRITERIA FOR POINT-OF-CARE TESTING DEVICES |
CLSI I/LA32 P : 1ED 2009
|
NEWBORN SCREENING BY TANDEM MASS SPECTROMETRY |
CLSI MM6 A2 : 2ED 2010
|
QUANTITATIVE MOLECULAR METHODS FOR INFECTIOUS DISEASES |
CLSI C51 P : 1ED 2010
|
EXPRESSION OF MEASUREMENT UNCERTAINTY IN LABORATORY MEDICINE |
CLSI C34 A3 : 3ED 2009
|
SWEAT TESTING: SAMPLE COLLECTION AND QUANTITATIVE CHLORIDE ANALYSIS |
CLSI MM17 A : 1ED 2008
|
VERIFICATION AND VALIDATION OF MULTIPLEX NUCLEIC ACID ASSAYS |
DIN EN ISO 15189:2014-11
|
Medical laboratories - Requirements for quality and competence (ISO 15189:2012, Corrected version 2014-08-15) |
UNI EN ISO 15189 : 2013
|
MEDICAL LABORATORIES - REQUIREMENTS FOR QUALITY AND COMPETENCE |
CLSI EP31 A : 1ED 2008
|
VERIFICATION OF COMPARABILITY OF PATIENT RESULTS WITHIN ONE HEALTH CARE SYSTEM |
CLSI MM19 P : 1ED 2011
|
ESTABLISHING MOLECULAR TESTING IN CLINICAL LABORATORY ENVIRONMENTS |
CLSI NBS05 A : 1ED 2011
|
NEWBORN SCREENING FOR CYSTIC FIBROSIS |
CLSI H59 P : 1ED 2010
|
QUANTITATIVE D-DIMER FOR THE EXCLUSION OF VENOUS THROMBOEMBOLIC DISEASE |
CLSI QMS01 A4 : 4ED 2011
|
QUALITY MANAGEMENT SYSTEM: A MODEL FOR LABORATORY SERVICES |
CLSI MM1 A2 : 2ED 2006
|
MOLECULAR DIAGNOSTIC METHODS FOR GENETIC DISEASES |
CLSI GP37 P : 1ED 2011
|
QUALITY MANAGEMENT SYSTEM: EQUIPMENT |
CLSI H47 A2 : 2ED 2008
|
ONE-STAGE PROTHROMBIN TIME (PT) TEST AND ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) TEST |
CLSI H57 P : 1ED 2007
|
PROTOCOL FOR THE EVALUATION, VALIDATION, AND IMPLEMENTATION OF COAGULOMETERS |
CLSI C50 P : 1ED 2007
|
MASS SPECTROMETRY IN THE CLINICAL LABORATORY: GENERAL PRINCIPLES AND GUIDANCE |
CLSI C54 P : 1ED 2007
|
VERIFICATION OF COMPARABILITY OF PATIENT RESULTS WITHIN ONE HEALTH CARE SYSTEM |
CLSI NBS04 A : 1ED 2010
|
NEWBORN SCREENING BY TANDEM MASS SPECTROMETRY
|
CLSI MM19 A : 1ED 2011
|
ESTABLISHING MOLECULAR TESTING IN CLINICAL LABORATORY ENVIRONMENTS |
ISO 15189:2012
|
Medical laboratories — Requirements for quality and competence |
BS EN ISO 15189:2012
|
Medical laboratories. Requirements for quality and competence |
CLSI GP34 A : 1ED 2010
|
VALIDATION AND VERIFICATION OF TUBES FOR VENOUS AND CAPILLARY BLOOD SPECIMEN COLLECTION |
CLSI GP16-A3 : 2009
|
Urinalysis; Approved Guideline—Third Edition |
CLSI H26 A2 : 2ED 2010
|
VALIDATION, VERIFICATION, AND QUALITY ASSURANCE OF AUTOMATED HEMATOLOGY ANALYZERS |
CLSI QMS13 A : 1ED 2011
|
QUALITY MANAGEMENT SYSTEM: EQUIPMENT |
CLSI H59 A : 1ED 2011
|
QUANTITATIVE D-DIMER FOR THE EXCLUSION OF VENOUS THROMBOEMBOLIC DISEASE |
CLSI EP9 A3 : 3ED 2013
|
MEASUREMENT PROCEDURE COMPARISON AND BIAS ESTIMATION USING PATIENT SAMPLES |
CLSI EP22 P : 1ED 2010
|
PRESENTATION OF A MANUFACTURER'S RISK MITIGATION INFORMATION FOR USERS OF IN VITRO DIAGNOSTIC DEVICES |
CLSI C50 A : 1ED 2007
|
MASS SPECTROMETRY IN THE CLINICAL LABORATORY: GENERAL PRINCIPLES AND GUIDANCE |
CLSI POCT12 A3 : 3ED 2013
|
Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities; Approved Guideline—Third Edition
|